Related Experiment Video
Updated: Mar 2, 2026
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Accelerating access and scale-up of optimized ART in low-income and middle-income countries: a call for a coordinated
Emily Harris1, Carmen Pérez-Casas, Matthew Barnhart
1aUNITAID, Geneva, Switzerland bUnited States Agency for International Development (USAID), Office of HIV/AIDS cUnited States Agency for International Development (USAID), Center for Accelerating Innovation and Impact, Washington, District of Columbia dUnited States Agency for International Development (USAID), Office of the Assistant Administrator for Global Health, USA.
Purpose Of Review:
To discuss how aligning the collective power of scientists, regulators, drug companies, donors, implementers and advocates to achieve a single goal - accelerating access to simpler, safer, more robust and more affordable HIV treatment - can rapidly advance antiretroviral optimization efforts and enable scale-up.
Recent Findings:
Harmonization of traditionally sequential processes can address the delays commonly experienced in introducing new products to low-income and middle-income countries, by facilitating an 'end-to-end' approach that mitigates risk and encourages early planning for all aspects of product introduction.
Summary:
Planning with the 'end-in-mind' can facilitate healthy markets, benefit the application of new technologies, and accelerate the development of improved products in parallel (versus traditionally sequential efforts).
